Abstract
A series of 4,5-disubstituted-1,2,4-triazole-3-thione derivatives (4a-e) and their N-Mannich bases (5a-e), together with a S-benzyl derivative (6), were synthesized and evaluated as antimycobacterial and antiproliferative agents. The structures of the compounds were established by IR, 1H-NMR, 13C-NMR and 2D-NMR spectroscopic methods and microanalysis. 4 and 5 were screened for in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv (ATCC 27294). Three of the tested compounds (4d, 4e and 5e) were found to be active in the primary screen. Among them, compound 4e was the most potent one with IC90 and IC50 values of 27.5 and 20.8 µg/mL, respectively. Additionally, compounds 4b, 4c, 5b, 5c, 5e and 6 were subjected to the NCI’s in vitro disease-oriented antitumor screening to be evaluated for antitumor activity at a single dose of 10 µM. The S-benzyl derivative 6 exhibited promising antiproliferative activity against leukemia CCRF-CEM, RPMI-8226 and SR, non-small cell lung cancer HOP-92, melanoma UACC-62 and renal cancer UO-31 cell lines.
Keywords: Antimycobacterial activity, Antitumor activity, Mannich bases, 1, 2, 4-Triazole-3-thiones.
Letters in Drug Design & Discovery
Title:Synthesis, Characterization, Antimycobacterial and Anticancer Evaluation of New 1,2,4-Triazole Derivatives
Volume: 11 Issue: 3
Author(s): G. Cihan-Ustundag, B. Simsek, E. Ilhan and G. Capan
Affiliation:
Keywords: Antimycobacterial activity, Antitumor activity, Mannich bases, 1, 2, 4-Triazole-3-thiones.
Abstract: A series of 4,5-disubstituted-1,2,4-triazole-3-thione derivatives (4a-e) and their N-Mannich bases (5a-e), together with a S-benzyl derivative (6), were synthesized and evaluated as antimycobacterial and antiproliferative agents. The structures of the compounds were established by IR, 1H-NMR, 13C-NMR and 2D-NMR spectroscopic methods and microanalysis. 4 and 5 were screened for in vitro antimycobacterial activity against Mycobacterium tuberculosis H37Rv (ATCC 27294). Three of the tested compounds (4d, 4e and 5e) were found to be active in the primary screen. Among them, compound 4e was the most potent one with IC90 and IC50 values of 27.5 and 20.8 µg/mL, respectively. Additionally, compounds 4b, 4c, 5b, 5c, 5e and 6 were subjected to the NCI’s in vitro disease-oriented antitumor screening to be evaluated for antitumor activity at a single dose of 10 µM. The S-benzyl derivative 6 exhibited promising antiproliferative activity against leukemia CCRF-CEM, RPMI-8226 and SR, non-small cell lung cancer HOP-92, melanoma UACC-62 and renal cancer UO-31 cell lines.
Export Options
About this article
Cite this article as:
Cihan-Ustundag G., Simsek B., Ilhan E. and Capan G., Synthesis, Characterization, Antimycobacterial and Anticancer Evaluation of New 1,2,4-Triazole Derivatives, Letters in Drug Design & Discovery 2014; 11 (3) . https://dx.doi.org/10.2174/157018081131000074
DOI https://dx.doi.org/10.2174/157018081131000074 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Design, Synthesis, and Biological Evaluation of C-2 Substituted 3Hthieno[ 2,3-d]pyrimidin-4-one Derivatives as Novel FGFR1 Inhibitors
Medicinal Chemistry Mesothelioma - Update on Management
Current Respiratory Medicine Reviews Transcriptome Analysis of MDA-MB-231 Cells Treated with Fumosorinone Isolated from Insect Pathogenic Fungi
Anti-Cancer Agents in Medicinal Chemistry Role of Alterations in the Apoptotic Machinery in Sensitivity of Cancer Cells to Treatment
Current Pharmaceutical Design Anti-miRNA-23a Oligonucleotide Suppresses Glioma Cells Growth by Targeting Apoptotic Protease Activating Factor-1
Current Pharmaceutical Design A Novel Marine Drug, SZ–685C, Induces Apoptosis of MMQ Pituitary Tumor Cells by Downregulating miR–200c
Current Medicinal Chemistry Pharmacokinetic Properties of Rituximab
Reviews on Recent Clinical Trials Application of Carbon Nanotubes In Drug Delivery of Non-cancerous Diseases: A Review
Current Pharmaceutical Design Nanotechnology, A Tool for Diagnostics and Treatment of Cancer
Current Topics in Medicinal Chemistry Membrane Tyrosine Kinase Receptors Kit and FLT3 are an Important Targets for the Therapy of Acute Myeloid Leukemia
Current Cancer Therapy Reviews Molecular Markers of Angiogenesis and Metastasis in Lines of Oral Carcinoma after Treatment with Melatonin
Anti-Cancer Agents in Medicinal Chemistry Advanced Glycation End Products (AGEs) and their Involvement in Liver Disease
Current Pharmaceutical Design Chitosan Nanoparticles as a Carrier for Indigofera intricata Plant Extract: Preparation, Characterization and Anticancer Activity
Current Cancer Therapy Reviews Crocetin: an Agent Derived from Saffron for Prevention and Therapy for Cancer
Current Pharmaceutical Biotechnology The Daphniphyllum Alkaloids
Current Organic Chemistry Editorial [Hot Topic: Angiogenesis Agents (Executive Editor: Cezary Marcinkiewicz)]
Current Pharmaceutical Design Human Insulin Genome Sequence Map, Biochemical Structure of Insulin for Recombinant DNA Insulin
Mini-Reviews in Medicinal Chemistry AKT Signaling in Regulating Angiogenesis
Current Cancer Drug Targets Energetics of Quadruplex-Drug Recognition in Anticancer Therapy
Current Cancer Drug Targets Vitamin D and Cancer Mortality: Systematic Review of Prospective Epidemiological Studies
Anti-Cancer Agents in Medicinal Chemistry